Search

Your search keyword '"Rolf I Skotheim"' showing total 70 results

Search Constraints

Start Over You searched for: Author "Rolf I Skotheim" Remove constraint Author: "Rolf I Skotheim"
70 results on '"Rolf I Skotheim"'

Search Results

1. GRIN3A: A biomarker associated with a cribriform pattern and poor prognosis in prostate cancer

2. High frequency of fusion transcripts involving TCF7L2 in colorectal cancer: novel fusion partner and splice variants.

3. Assessment of fusion gene status in sarcomas using a custom made fusion gene microarray.

4. Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcoma.

5. Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma.

6. A tumor-associated mutation of FYVE-CENT prevents its interaction with Beclin 1 and interferes with cytokinesis.

7. Phospholipase C isozymes are deregulated in colorectal cancer--insights gained from gene set enrichment analysis of the transcriptome.

8. Cysteine-rich secretory protein-3 (CRISP3) is strongly up-regulated in prostate carcinomas with the TMPRSS2-ERG fusion gene.

9. Data from Three Epigenetic Biomarkers, GDF15, TMEFF2, and VIM, Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine Samples

10. Data from ColoGuidePro: A Prognostic 7-Gene Expression Signature for Stage III Colorectal Cancer Patients

11. Supplemental Materials, Figures S1-6, Tables S1-4 from Regulator of Chromosome Condensation 2 Identifies High-Risk Patients within Both Major Phenotypes of Colorectal Cancer

13. Supplementary Methods, Tables 1-2, Figures 1-4 from ColoGuidePro: A Prognostic 7-Gene Expression Signature for Stage III Colorectal Cancer Patients

14. Data from Regulator of Chromosome Condensation 2 Identifies High-Risk Patients within Both Major Phenotypes of Colorectal Cancer

15. Supplementary Figure S3 from TMPRSS2 Fusions with Oncogenic ETS Factors in Prostate Cancer Involve Unbalanced Genomic Rearrangements and Are Associated with HDAC1 and Epigenetic Reprogramming

16. Data from Oncogenicity of the Developmental Transcription Factor Sox9

17. Supplementary Table 4 from Differentiation of Human Embryonal Carcinomas In vitro and In vivo Reveals Expression Profiles Relevant to Normal Development

18. Supplementary Table 5 from Differentiation of Human Embryonal Carcinomas In vitro and In vivo Reveals Expression Profiles Relevant to Normal Development

19. Supplementary Table S4-S6 from TMPRSS2 Fusions with Oncogenic ETS Factors in Prostate Cancer Involve Unbalanced Genomic Rearrangements and Are Associated with HDAC1 and Epigenetic Reprogramming

20. Data from Identification of Novel Fusion Genes in Testicular Germ Cell Tumors

21. Supplementary Table 3 from Differentiation of Human Embryonal Carcinomas In vitro and In vivo Reveals Expression Profiles Relevant to Normal Development

22. Supplementary Table 2A from Differentiation of Human Embryonal Carcinomas In vitro and In vivo Reveals Expression Profiles Relevant to Normal Development

23. Supplementary Table 1 from Differentiation of Human Embryonal Carcinomas In vitro and In vivo Reveals Expression Profiles Relevant to Normal Development

24. Supplementary Table S1 from TMPRSS2 Fusions with Oncogenic ETS Factors in Prostate Cancer Involve Unbalanced Genomic Rearrangements and Are Associated with HDAC1 and Epigenetic Reprogramming

25. Data from Differentiation of Human Embryonal Carcinomas In vitro and In vivo Reveals Expression Profiles Relevant to Normal Development

26. Supplementary Tables 1 through 4 and Supplementary Figures 1 and 2 from Identification of Novel Fusion Genes in Testicular Germ Cell Tumors

27. Data from TMPRSS2 Fusions with Oncogenic ETS Factors in Prostate Cancer Involve Unbalanced Genomic Rearrangements and Are Associated with HDAC1 and Epigenetic Reprogramming

29. Supplementary Figures 1-2 from Differentiation of Human Embryonal Carcinomas In vitro and In vivo Reveals Expression Profiles Relevant to Normal Development

32. Deviating Alternative Splicing as a Molecular Subtype of Microsatellite Stable Colorectal Cancer

33. In situ expression of ERG protein in the context of tumor heterogeneity identifies prostate cancer patients with inferior prognosis

34. NRF2 drives an oxidative stress response predictive of breast cancer

35. Association study between polymorphisms in DNA methylation-related genes and testicular germ cell tumor risk

36. Somatic mutations reveal complex metastatic seeding from multifocal primary prostate cancer

38. Expressed prognostic biomarkers for primary prostate cancer independent of multifocality and transcriptome heterogeneity

39. Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci

41. Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer

42. Exome Sequencing of Bilateral Testicular Germ Cell Tumors Suggests Independent Development Lineages

43. Transcriptome instability as a molecular pan-cancer characteristic of carcinomas

44. A novel transcript, VNN1-AB, as a biomarker for colorectal cancer

45. Chromosome 19 rearrangements in ovarian carcinomas: zinc finger genes are particularly targeted

46. High frequency of fusion transcripts involving TCF7L2 in colorectal cancer: novel fusion partner and splice variants

47. [Genome sequencing for personalized cancer treatment]

48. New insights into testicular germ cell tumorigenesis from gene expression profiling

49. The expressed mutational landscape of microsatellite stable colorectal cancers

50. Identification of 22 susceptibility loci associated with testicular germ cell tumors

Catalog

Books, media, physical & digital resources